BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Debt History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹28 Cr | ₹24 Cr | ₹23 Cr | ₹11 Cr | ₹13 Cr |
What is the latest Total Debt ratio of BAFNA PHARMACEUTICALS ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹28 Cr |
| Mar2024 | ₹24 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹13 Cr |
How is Total Debt of BAFNA PHARMACEUTICALS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹28 Cr | 15.62 | |
| Mar2024 | ₹24 Cr | 6.39 | |
| Mar2023 | ₹23 Cr | 107.27 | |
| Mar2022 | ₹11 Cr | -14.92 | |
| Mar2021 | ₹13 Cr | - | |
Compare Total Debt of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹601.4 Cr | 6.8% | 25.3% | 231% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 6.8% |
25.3% |
231% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses